Reozalimab is a bispecific antibody engineered to target both PD-1 and PD-L1. This unique formulation enhances the immune response against tumor cells by facilitating antibody-dependent cell-mediated cytotoxicity (ADCC). It is primarily utilized in oncological research to investigate immune checkpoint blockade therapies.
Reozalimab is a bispecific antibody engineered to target both PD-1 and PD-L1. This unique formulation enhances the immune response against tumor cells by facilitating antibody-dependent cell-mediated cytotoxicity (ADCC). It is primarily utilized in oncological research to investigate immune checkpoint blockade therapies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
